Trualt Bioenergy IPO is a book-built issue totaling ₹839.28 crore. The IPO comprises a fresh issue of approximately 1.51 crore equity shares, amounting to ₹750 crore, along with an Offer for Sale (OFS) of 0.18 crore shares worth ₹89.28 crore.
The IPO subscription window opened on September 25, 2025, and will remain open until September 29, 2025. The basis of allotment is expected to be finalized on September 30, 2025, with the shares anticipated to be listed on both the BSE and NSE on October 3, 2025.
The price band for the IPO is set between ₹472 to ₹496 per share. Investors can bid in lots of 30 shares, translating to a minimum investment of ₹14,880 for retail investors, assuming the upper end of the price band.
Trualt Bioenergy is hitting the capital markets with a ₹839.28 crore IPO, structured as a book-built issue. This offering includes a fresh issue of 1.51 crore shares totaling ₹750 crore, along with an Offer for Sale (OFS) of 0.18 crore shares amounting to ₹89.28 crore.
The IPO opened for subscription on September 25, 2025, and will close on September 29, 2025. The share allotment is likely to be finalized on September 30, 2025, with the company expected to make its stock market debut on the BSE and NSE on October 3, 2025. The price band for the issue is set at ₹472–₹496 per share.
The table below breaks down the Trualt Bioenergy share allocation for different categories, highlighting the number of shares and their percentage of the total issue. However, the key focus remains on the quotas allocated to retail investors and HNIs, as they are the most relevant for individual investors.
| Investor Category | Shares Offered |
| QIB (Qualified Institutional Buyers) | Not more than 50% of the Net Offer |
| Retail Individual Investors | Not less than 35% of the Net Offer |
| NII (Non-Institutional Investors) | Not less than 15% of the Net Offer |
Data Source: NSE
| Category | Subscription (times) |
| Qualified Institutional Buyers | 15.67 |
| Non-Institutional Investors | 64.03 |
| Retail Individual Investors | 7.15 |
| Total shares | 21.77 |
Note: The subscription details are as of September 29, 2025
Founded in 2021, Trualt Bioenergy Limited is a fast-growing player in India’s renewable energy sector, primarily focused on biofuel production with a strong emphasis on ethanol. The company is currently one of India’s largest ethanol producers by installed capacity, boasting a production capability of 2,000 kilolitres per day (KLPD). As of FY2025, Trualt holds a 3.6% share in the country’s total ethanol production capacity.
Trualt’s business footprint extends beyond ethanol into compressed biogas (CBG). As of March 31, 2025, its subsidiary Leafinity operates a CBG plant with a daily production capacity of 10.20 tonnes. In a bid to scale this segment, the company has signed Memorandums of Understanding (MoUs) with a prominent Japanese gas company and Sumitomo Corporation Asia & Oceania Pte. Ltd., signaling its intent to expand its footprint in the biogas space.
Know more about IPO allotment status and check your application details online for the latest updates on share allocation.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Sep 29, 2025, 2:35 PM IST
Sachin Gupta
Sachin Gupta is a Content Writer with 6+ years of experience in the stock market, including global markets like the US, Canada, and Australia. At Angel One, Sachin specialises in creating financial content that simplifies complex market trends. Sachin holds a Master's in Commerce, specialising in Economics.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
